Home › Investors short Juno Therapeutics, Amgen stocks, but that may not be bad news
 

Keywords :   


Investors short Juno Therapeutics, Amgen stocks, but that may not be bad news

2015-03-03 04:12:21| Biotech - Topix.net

More investors were shorting their biotech stocks in the first half of February than in the previous month, according to financial news site Benzinga . Of the top three companies with the most short sells, two have Puget Sound ties: Seattle-based Juno Therapeutics and California-based Amgen , which has offices in Bothell and Seattle until the end of the year.

Tags: news short bad stocks

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
02.11Subtropical Storm Patty Update Statement
02.11Summary for Subtropical Storm Patty (AT2/AL172024)
02.11Atlantic Tropical Weather Outlook
02.11Eastern North Pacific Tropical Weather Outlook
02.11Weekly Recap: Nippon Paint, AkzoNobel, PPG Top This Weeks Stories
02.11Subtropical Storm Patty Graphics
02.11Subtropical Storm Patty Forecast Discussion Number 1
02.11Subtropical Storm Patty Wind Speed Probabilities Number 1
More »